IP Verse

Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid Salt

EP3995135

GRÜNENTHAL GMBH
Application Number
EP20206800A
Filing Date
Nov 10, 2020
Status
Granted And Under Opposition
Jun 10, 2022
Grant Date
Jul 13, 2022
External Links
Slate, Register

Biblio Summary

The patent EP3995135B1 was granted on Jul 13, 2022 by Grünenthal Gmbh The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZSep 30, 2022WITHDRAWN
INSUD PHARMA SLJul 13, 2022WITHDRAWN

More Opposed Patents of Grünenthal Gmbh

The table below shows the patents of Grünenthal Gmbh that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3210965Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolNov 17, 20213
EP3656765Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolApr 14, 20216
EP3241550(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful InflammationsJul 22, 20204

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents